Skip to content

Episode Notes

Source / episode info

One-liner

The concluding chapter of the Pharmacology Crash Course covers antineoplastic classes, cell-cycle specificity, organ-specific chemotoxicities and their rescue antidotes, immunosuppressants, and universal board poison antidotes.

High-yield summary

  • Antimetabolites (S-Phase Specific): Methotrexate inhibits dihydrofolate reductase (DHFR); causes myelosuppression, hepatotoxicity, and pulmonary fibrosis; rescued by Leucovorin (folinic acid bypasses DHFR). 5-Fluorouracil (5-FU) inhibits thymidylate synthase; enhanced by leucovorin (unlike MTX!); causes myelosuppression and hand-foot syndrome. 6-Mercaptopurine (6-MP) and Azathioprine are metabolized by xanthine oxidase; co-administration with allopurinol leads to massive toxic accumulation and fatal pancytopenia (requires 75% dose reduction).
  • DNA Alkylating & Cross-Linking Agents: Cyclophosphamide cross-links DNA at guanine N-7; metabolized to acrolein which causes severe hemorrhagic cystitis and bladder transitional cell carcinoma; prevented with aggressive hydration and MESNA (2-mercaptoethanesulfonate binds acrolein). Cisplatin & Carboplatin cross-link DNA; cause nephrotoxicity (acute tubular necrosis) and ototoxicity (acoustic nerve damage); prevented with Amifostine (free radical scavenger) and aggressive chloride diuresis.
  • Microtubule Inhibitors (M-Phase Specific): Vincristine and Vinblastine bind beta-tubulin and prevent microtubule polymerization. "Vincristine crisps the nerves" (peripheral sensorimotor neuropathy, paralytic ileus). "Vinblastine blasts the marrow" (severe bone marrow suppression). Paclitaxel and docetaxel hyper-stabilize microtubules, preventing depolymerization.
  • Organ-Specific Chemotherapy Toxicities: Anthracyclines (Doxorubicin, Daunorubicin) generate iron-mediated free radicals, causing dilated cardiomyopathy and congestive heart failure; prevented with Dexrazoxane (iron chelator). Bleomycin causes pulmonary fibrosis and hyperpigmentation (along with Busulfan and Methotrexate). Trastuzumab (anti-HER2) causes reversible cardiotoxicity (decreased ejection fraction without myocyte necrosis, unlike anthracyclines).
  • Calcineurin Inhibitors: Tacrolimus (binds FKBP-12) and Cyclosporine (binds cyclophilin) inhibit calcineurin, preventing NFAT dephosphorylation and blocking IL-2 transcription. Both are nephrotoxic (afferent arteriolar vasoconstriction). Cyclosporine uniquely causes gingival hyperplasia and hirsutism. Sirolimus (Rapamycin) inhibits mTOR, preventing response to IL-2; causes pancytopenia and hyperlipidemia, but is NOT nephrotoxic ("kidney-sparing").
  • High-Yield Poison Antidotes: Acetaminophen -> N-acetylcysteine (restores hepatic glutathione). Beta-blockers -> Glucagon (stimulates adenylate cyclase independent of beta receptors). Carbon monoxide -> 100% O2 / Hyperbaric oxygen. Cyanide -> Hydroxocobalamin or Sodium Nitrite + Sodium Thiosulfate. Heparin -> Protamine sulfate. Warfarin -> Vitamin K + 4-factor Prothrombin Complex Concentrate (PCC). Methanol / Ethylene glycol -> Fomepizole (inhibits alcohol dehydrogenase). Organophosphates -> Atropine + Pralidoxime. Opioids -> Naloxone. Benzodiazepines -> Flumazenil.

Learning objectives

  • Pair chemotherapeutic agents with their organ-specific toxicities and corresponding chemoprotective antidotes.
  • Explain the drug interaction between azathioprine/6-MP and allopurinol.
  • Differentiate the mechanism and side effect profiles of Tacrolimus, Cyclosporine, and Sirolimus.
  • Select the appropriate clinical antidote for common toxicology ingestions on Step 2, Step 3, and COMLEX.
  • Distinguish reversible (Trastuzumab) from irreversible (Doxorubicin) chemotherapeutic cardiotoxicity.

Board exam buzzwords

Chemo Agent / ToxinPrimary MechanismCharacteristic Organ ToxicitySpecific Antidote / Rescue
CyclophosphamideAlkylates DNA, generates acrolein metaboliteHemorrhagic cystitis, bladder cancerMESNA + vigorous intravenous hydration.
DoxorubicinFree radical generation & topoisomerase II inhibitionDilated cardiomyopathy (congestive heart failure)Dexrazoxane (iron-chelating free-radical scavenger).
MethotrexateInhibits dihydrofolate reductase (DHFR)Myelosuppression, mucositis, pulmonary fibrosisLeucovorin (folinic acid). Glucarpidase in severe acute renal failure.
CisplatinDNA cross-linking (platinum analog)Nephrotoxicity, ototoxicity, peripheral neuropathyAmifostine + aggressive IV saline diuresis.
BleomycinFree radical DNA strand breaksPulmonary fibrosis, hyperpigmentationMonitor DLCO; cumulative lifetime dose cap.
Ethylene GlycolMetabolized by alcohol dehydrogenase to oxalic acidAnion-gap metabolic acidosis, envelope-shaped oxalate crystals in urine, AKIFomepizole (competitive inhibitor of alcohol dehydrogenase).

Rapid review table

Toxin / Drug OverdoseAntidote of ChoiceMechanism of Antidote
AcetaminophenN-acetylcysteine (NAC)Replenishes hepatic glutathione; binds toxic NAPQI metabolite
Beta-blocker overdoseGlucagonActivates Gs protein-coupled receptor, increasing cAMP independent of beta-1 receptors
Heparin toxicityProtamine sulfatePositively charged peptide binds and neutralizes negatively charged heparin
Warfarin major bleed4-Factor PCC + IV Vitamin KRapidly replaces vitamin K-dependent clotting factors (II, VII, IX, X, Protein C & S)
Methanol / Ethylene GlycolFomepizoleCompetitively inhibits alcohol dehydrogenase, preventing toxic acid metabolite formation
Cyanide toxicityHydroxocobalaminBinds cyanide with high affinity to form nontoxic cyanocobalamin (Vitamin B12), excreted in urine

Board-speak -> diagnosis

Vignette ClueTarget Concept / DiagnosisWhy It Fits
Vignette ClueUnderlying Pharmacologic PathologyCorrect Clinical Action
Gout patient on allopurinol started on azathioprine for Crohn disease presents with severe fever, mouth sores, and absolute neutrophil count of 120 /mcL.Xanthine oxidase inhibition by allopurinol blocks 6-MP breakdown, causing catastrophic pancytopenia.Stop drugs immediately; administer G-CSF (filgrastim) and broad-spectrum empiric antibiotics.
Breast cancer patient on doxorubicin develops orthopnea, paroxysmal nocturnal dyspnea, and EF drop from 60% to 32%.Doxorubicin-induced free-radical myocyte necrosis and myofibrillar dropout.Discontinue doxorubicin; initiate standard heart failure guideline-directed medical therapy.
Renal transplant recipient on tacrolimus and mycophenolate develops rising creatinine from 1.1 to 2.3 mg/dL without rejection on biopsy.Calcineurin inhibitor-induced renal afferent arteriolar vasoconstriction.Check trough tacrolimus level; reduce dosage to restore normal glomerular hemodynamics.

Management pearls

  • Trastuzumab (Herceptin) cardiotoxicity is "Type II" (stunned myocardium without myocyte destruction, dose-independent, reversible upon stopping). Anthracycline cardiotoxicity is "Type I" (myocyte death with vacuolization, cumulative dose-dependent, irreversible).
  • In ethylene glycol ingestion, wood lamp examination of urine can reveal fluorescence because commercial antifreeze contains sodium fluorescein dye.
  • Flumazenil can precipitate acute withdrawal seizures in benzodiazepine-dependent patients or in mixed overdoses with tricyclic antidepressants. Use extreme caution!

Don't miss

🚨 Azathioprine + Allopurinol Lethal Interaction: If a question mentions starting azathioprine or 6-MP in a patient taking allopurinol or febuxostat, the dose MUST be reduced by 75%, or severe fatal bone marrow aplasia will occur.
🚨 Leucovorin in MTX vs 5-FU: Leucovorin RESCUES bone marrow in methotrexate toxicity by bypassing DHFR. However, in 5-FU therapy, leucovorin ENHANCES the cytotoxic efficacy of 5-FU by stabilizing the thymidylate synthase complex.

Original transcript with highlights

Original transcript with highlights

All right, welcome. This is Episode 673: "USMLE Pharm Crash Course Part 4: Chemotherapy, Immunosuppressants & Toxicology Antidotes." This concludes our 4-part pharmacology crash course, and we are focusing on antineoplastic mechanisms, organ toxicities with their rescue agents, immunosuppressants, and board-tested poison antidotes.

Let's look at antimetabolites (S-phase specific). Methotrexate competitively inhibits Dihydrofolate Reductase (DHFR), depleting tetrahydrofolate. What is the rescue agent for high-dose methotrexate toxicity? LEUCOVORIN (folinic acid)! Why? Because Leucovorin bypasses DHFR and directly replenishes downstream folate pools. Now, contrast that with 5-Fluorouracil (5-FU). 5-FU inhibits thymidylate synthase. Does Leucovorin rescue 5-FU? NO! In fact, Leucovorin ENHANCES 5-FU efficacy by stabilizing the enzyme-drug complex! Make sure you don't confuse MTX rescue with 5-FU enhancement on test day!

What is the most famous lethal drug interaction in antimetabolite therapy? Azathioprine and 6-Mercaptopurine (6-MP)! Azathioprine is converted to 6-MP, which is metabolized by Xanthine Oxidase. If a patient with leukemia or inflammatory bowel disease is taking azathioprine, and they get gout and a physician starts Allopurinol or Febuxostat, Xanthine Oxidase is blocked. 6-MP accumulates to catastrophic levels, causing fatal bone marrow aplasia and pancytopenia! You must reduce the azathioprine dose by 75%.

Let's pair chemo agents with their toxicities and rescue antidotes: Cyclophosphamide causes acrolein-induced hemorrhagic cystitis and bladder cancer -> Rescue with MESNA and vigorous hydration. Doxorubicin generates iron-mediated free radicals causing dilated cardiomyopathy -> Rescue with Dexrazoxane (iron chelator). Cisplatin causes nephrotoxicity and ototoxicity -> Rescue with Amifostine and saline diuresis. Vincristine causes peripheral neuropathy ("crisps the nerves"), while Vinblastine causes myelosuppression ("blasts the marrow"). Bleomycin and Busulfan cause pulmonary fibrosis. And for toxicology: Acetaminophen -> N-acetylcysteine. Beta-blockers -> Glucagon. Cyanide -> Hydroxocobalamin. Methanol or ethylene glycol -> Fomepizole. Heparin -> Protamine. Warfarin -> 4-factor PCC + Vitamin K. Organophosphates -> Atropine + Pralidoxime. These pairings are pure, unadulterated board points!

OMM / COMLEX integration

🦴
High-Yield Viscerosomatics & Biomechanics for COMLEX candidates:
  • Hepatic and biliary viscerosomatic reflexes: T5–T9 sympathetics on the right side. In patients undergoing hepatotoxic chemotherapy (methotrexate, azathioprine), palpatory tissue changes along the right thoracic paraspinal region correlate with hepatic stress.
  • Lymphatic drainage: Normalizing somatic dysfunction at the thoracic inlet and rib cage ensures optimal thoracic duct flow, which is vital for clearing tissue edema and metabolites in patients recovering from toxic insults.